August 2025 FDA Recall Cyclobenzaprine Hydrochloride by Unichem Pharmaceuticals Usa Inc.
D-0655-2025 - Labeling

This Class I drug recall was voluntarily initiated by Unichem Pharmaceuticals Usa Inc. on August 27, 2025 for the product Cyclobenzaprine Hydrochloride. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0655-2025

Reason for Recall
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
Initiated
08-27-2025
Reported
09-24-2025
Quantity
230 90-count bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Unichem Pharmaceuticals USA Inc.
Nationwide within the U.S.A
Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.

Batch or Lot Expiration Information

Lot# Lot No: GMML24026A, Expires: 09/30/2027